KraneShares MSCI All China Health Care Index ETF (KURE)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in KraneShares MSCI All China Health Care Index ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

KraneShares MSCI All China Health Care Index ETF (KURE) has returned 0.18% so far this year and 13.79% over the past 12 months.

Based on dividend-adjusted daily data since Feb 1, 2018, KURE's average daily return is +0.01%, while the average monthly return is +0.15%. At this rate, your investment would double in approximately 38.5 years.

Historically, 50% of months were positive and 50% were negative. The best month was Sep 2024 with a return of +21.9%, while the worst month was Jan 2024 at -19.0%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.

On a daily basis, KURE closed higher 50% of trading days. The best single day was Mar 16, 2022 with a return of +11.9%, while the worst single day was Mar 16, 2020 at -14.2%.

KraneShares MSCI All China Health Care Index ETF has an annualized alpha of -4.18%, beta of 0.61, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since February 02, 2018.

• This ETF participated in 60.36% of S&P 500 Index downside but only 22.86% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.61 may look defensive, but with R² of 0.13 this ETF is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
• R² of 0.13 means this ETF moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

KURE has an expense ratio of 0.65%, placing it in the medium range.

KURE ranks 25 for risk / return — below 25% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for KraneShares MSCI All China Health Care Index ETF (KURE) and compare them to a chosen benchmark (S&P 500 Index).

KraneShares MSCI All China Health Care Index ETF provided a 4.19% dividend yield over the last twelve months, with an annual payout of $0.71 per share. The fund has been increasing its distributions for 3 consecutive years.

The table displays the monthly dividend distributions for KraneShares MSCI All China Health Care Index ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the KraneShares MSCI All China Health Care Index ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the KraneShares MSCI All China Health Care Index ETF was 68.53%, occurring on Jul 8, 2024. The portfolio has not yet recovered.

The current KraneShares MSCI All China Health Care Index ETF drawdown is 56.38%.

The chart below shows the rolling one-month volatility.